Protein gene product 9.5 is expressed by fibroblasts in human cutaneous wounds.
In a study initially designed to evaluate reinnervation of human cutaneous wounds using an antibody to the neuroneal marker protein gene product (PGP) 9.5, we observed marked immunostaining of cells with morphologic features of fibroblasts in the wounds. PGP 9.5 has recently been shown to be an important enzyme in the highly conserved ubiquitin system of proteolysis. Because the ubiquitin system is known to play an important role in regulating the cell cycle, the presence of PGP 9.5 in cells at a wound site was of considerable interest. Our objectives were to clarify the time frame for the appearance of PGP 9.5 and ubiquitin in wounds, to verify that PGP 9.5 is produced by wound fibroblasts, and to evaluate a potential role for these proteins in the tissue repair process. Standard incisional human wounds were stained with antibodies specific for PGP 9.5 and ubiquitin. At 7 d, stellate cells with morphologic features of fibroblasts stained for PGP 9.5, whereas earlier wounds were generally negative. In 14 and 21 d incised wounds and in chronic granulation tissue from nonhealing ulcers there was strong cellular staining for PGP 9.5 and for ubiquitin. These stellate cells also showed expression of mRNA for PGP 9.5 by reverse transcriptase-polymerase chain reaction in situ hybridization. PGP 9.5 was detected in cultured fibroblasts both by reverse transcriptase-polymerase chain reaction and by northern blot analysis. Confocal microscopy showed colocalization of antibodies to PGP 9.5 and prolyl-4-hydroxylase (a fibroblast marker) as well as colocalization of PGP 9.5 and the platelet derived growth factor beta receptor. We conclude that ubiquitin and PGP 9.5 were expressed by fibroblasts during the granulation tissue and remodeling phases wound healing. The mRNA for PGP 9.5 was demonstrated in stellate cells in chronic wounds and in fibroblasts in culture. The appearance of these degradative proteins in later wounds suggests a downregulation function in the wound healing response.
Olerud
J E
JE
Department of Medicine, University of Washington, Seattle, USA.
Chiu
D S
DS
Usui
M L
ML
Gibran
N S
NS
Ansel
J C
JC
D017209:Apoptosis; D015152:Blotting, Northern; D018076:DNA, Complementary / Q000032:analysis; D005347:Fibroblasts / Q000737:chemistry* / Q000648:ultrastructure; D015870:Gene Expression; D005821:Genetic Techniques; D006801:Humans; D017403:In Situ Hybridization; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D017479:Receptors, Platelet-Derived Growth Factor; D013869:Thiolester Hydrolases / Q000096:biosynthesis* / Q000235:genetics; D013997:Time Factors; D043222:Ubiquitin Thiolesterase; D014452:Ubiquitins / Q000032:analysis; D014947:Wounds and Injuries / Q000473:pathology*
D018076:DNA, Complementary; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D014452:Ubiquitins; D017479:Receptors, Platelet-Derived Growth Factor; D013869:Thiolester Hydrolases; D043222:Ubiquitin Thiolesterase